It is also reported that miR-101 inhibits lung cancer invasion through regulation of EZH2 [41], which inhibits cell proliferation and invasion, but enhances paclitaxel-induced apoptosis in non-small cell lung cancer [40]. Here, EZH2 is linked to non-small cell lung carcinoma.